Last reviewed · How we verify

NCT05869695: SpanishOSPRO

Transcultural Adaptation and Validation to Spanish of the OSPRO Questionnaires

Status unknown Last updated 22 May 2023
What this trial tests

trial testing OSPRO-ROS Questionnaire in Musculoskeletal Pain in 200 participants. Status unknown.

Timeline
30 November 2020
Primary endpoint
31 December 2023
30 June 2024

Quick facts

Lead sponsorUniversity of Valencia
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date30 November 2020
Primary completion31 December 2023
Estimated completion30 June 2024
Sites2 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Valencia

Who can join

Adults 18 to 75, any sex, with Musculoskeletal Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical guidelines for managing musculoskeletal pain recommend first, assessing and identifying any signs of severe physical conditions (i.e."red flags") and then, asessing the psychosocial prognostic factors of poor outcomes (i.e."yellow flags"). The Optimal Sreening for Prediction of Referral and Outcome (OSPRO) cohort studies were designed to develop and validate standard assessment tools for Review Of Systems (OSPRO-ROS) and Yellow Flags (OSPRO-YF).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Musculoskeletal Pain

Currently open trials in the same condition.

Other University of Valencia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05869695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing